| ccRCC (N = 64) | non ccRCC (N = 22) | p value |
---|---|---|---|
M / F | 37 (58%) / 27 (42%) | 14 (64%) / 8 (36%) | 0.63 |
Age, median | 62.5 (35-87) | 60.5 (23-82) | 0.49 |
TNM classification | Â | Â | Â |
clinical T | Â | Â | 0.42 |
1 | 50 (78%) | 19 (86%) | Â |
2 | 5 (8%) | 2 (9%) | Â |
3 | 9 14%) | 1 (5%) | Â |
4 | 0 | 0 | Â |
clinical N | Â | Â | 0.06 |
0 | 64 (100%) | 20 (90%) | Â |
1 | 0 | 1 (5%) | Â |
2 | 0 | 1 (5%) | Â |
clinical M | Â | Â | 0.97 |
0 | 58 (91%) | 20 (90%) | Â |
1 | 6 (9%) | 2 (10%) | Â |
Grading | Â | Â | 0.18 |
1 | 8 (13%) | 1 (5%) | Â |
2 | 49 (76%) | 14 (64%) | Â |
3 | 6 (9%) | 5 (22%) | Â |
N.A. | 1 (2%) | 2 (9%) | Â |
pathological T | Â | Â | 0.13 |
1 | 47 (74%) | 19 (86%) | Â |
2 | 6 (9%) | 0 | Â |
3 | 11 (17%) | 3 (14%) | Â |
4 | 0 | 0 | Â |
INF | Â | Â | 0.15 |
a | 47 (73%) | 20 (90%) | Â |
b | 15 (24%) | 2 (10%) | Â |
c | 0 | 0 | Â |
N.A. | 2 (3%) | 0 | Â |
v | Â | Â | 0.31 |
0 | 46 (72%) | 19 (86%) | Â |
1 | 17 (16%) | 3 (14%) | Â |
N.A. | 1 (2%) | 0 | Â |
Tumor size (cm) | 3.5 (2.23 - 5.85) | 2.9 (2.23 - 4.55) | 0.41 |
CRP (mg/dl) | 0.13 (0.1-0.43) | 0.1 (0.1-0.81) | 0.90 |
LRG1 (ug/ml) | 63.2 (42.8 - 94.2) | 23.4 (17.7 - 29.6) | <0.0001 |